Neko Health, the preventive health startup co-founded by Spotify’s Daniel Ek and Hjalmar Nilsonne, has closed a $700 million Series C funding round, pushing its valuation to nearly $7 billion and marking one of the largest raises yet in the fast-growing body-scanning and longevity health sector. The round was led by Lightspeed Venture Partners and O.G. Venture Partners, with backing from returning investors including Atomico, General Catalyst and Lakestar.
Neko’s core offering is a roughly hour-long, radiation-free scan that pairs thousands of sensor readings with bloodwork to flag early signs of conditions ranging from skin irregularities to cardiovascular risk, with results reviewed by a physician the same day. The company says the approach has already been used in more than 100,000 appointments across its clinics in the UK and Sweden, with more than 350,000 additional people either on the waitlist or already booked for a scan.
The new funding round also drew a striking list of individual backers, including Meta’s Mark Zuckerberg and Priscilla Chan, tennis champion Maria Sharapova, former footballer Thierry Henry, model Claudia Schiffer and record executive Jimmy Iovine, underscoring the level of high-profile interest in preventive health technology. The investment follows a $260 million Series B round the company closed in January 2025, when it was valued at roughly $1.8 billion.
With the fresh capital in hand, Neko is turning its attention to the United States, where it plans to open its first clinic in New York later this year as part of a broader expansion into American cities. Ek and Nilsonne have not detailed exactly how the funding will be split between opening new locations and further developing Neko’s in-house scanning hardware and software, but the scale of the round signals investor confidence that consumers are increasingly willing to pay out of pocket for detailed, data-driven preventive care.
Source: techcrunch.com